WLWinnie Li

Winnie Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Winnie Li has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Amanda Moreira

    Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

    3 shared publications
  • Patricia Lindsay

    Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada

    2 shared publications
  • Peter Chung

    Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada

    2 shared publications
  • Alejandro Berlin

    Radiation Medicine Program, Princess Margaret Cancer Centre, University of Toronto, 610 University Ave, Toronto, ON M5G 2M9, Canada

    1 shared publication
  • Ali Hosni

    Radiation Medicine Program, Princess Margaret Cancer Centre Toronto Ontario Canada

    1 shared publication
  • Andrew Bayley

    Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada

    1 shared publication

Latest Publications

  • Open Access

    Transition from Oncologist- to Therapist-Led MRI-Guided Ultra-Hypofractionated Adaptive Prostate Radiation Therapy: Evaluation of Early Clinical Outcomes

    by Amanda Moreira, Tara Rosewall, Jennifer Dang, Aran Kim, Anna T. Santiago, Aruz Mesci, Enrique Gutierrez, Andrew Bayley, Andrew McPartlin, Rachel M. Glicksman, et al.

    MR-guided adaptive radiotherapy (ART) enables daily plan optimization for prostate cancer but is resource-intensive. This study evaluated dosimetric and clinical outcomes following transition from radiation oncologist (RO)-led to radiation therapist (RTT)-led MR-guided ART. All prostate cancer patients treated with MR-guided ART on a 1.5T MR-linac were retrospectively reviewed. Consecutive RO-led (September 2019–November 2021) and RTT-led (April 2022–October 2023) cohorts were compared, excluding the actual transition period. Toxicities (CTCAE v5.0), dose–volume metrics from daily adapted plans, target volume variation, and biochemical recurrence-free survival (BRFS) were analyzed. A total of 166 patients were included (78 RO-led, 88 RTT-led; median follow-up 40 and 35 months). Dosimetric differences between the cohorts were statistically small (n = 2 vs. n = 0), likely reflecting higher baseline urinary dysfunction; no post-treatment differences persisted. Early biochemical outcomes were comparable, with 36-month BRFS of 93.5% (RO-led) and 95.0% (RTT-led). RTT-led MR-guided ART achieved comparable dosimetric quality and early biochemical outcomes to RO-led workflows with adverse advents that resolved in the long term. With structured training and a mature practice setting, RTT-led ART represents a scalable model to support future adaptive radiotherapy practice.

  • A framework for upskilling Canadian Radiation Therapists for online adaptive radiation therapy

    by Amanda Moreira, Tara Rosewall, Jennifer Dang, Michael Velec, Nicole Harnett, Yat Tsang, Patricia Lindsay, Peter Chung, Winnie Li

  • Open Access

    Feasibility of Therapist‐Driven MR ‐Guided Adaptive Radiotherapy for Oligometastatic Disease: Geometric Accuracy and Dosimetric Impact

    by Amanda Moreira, Winnie Li, Iymad R. Mansour, Mame Faye, Ali Hosni, Aruz Mesci, Enrique Gutierrez‐Valencia, Patricia Lindsay, Peter Chung, Jeff Winter

    Introduction: MRI‐guided adaptive radiation therapy (ART) is the resource‐intensive process of daily treatment plan modification. This study aims to demonstrate the feasibility of radiation therapist (RT)‐led MRI‐guided ART for oligometastatic disease (OMD) by comparing geometric accuracy and dosimetric differences between RT and radiation oncologist (RO) re‐contouring. Methods: Five RTs and five ROs retrospectively re‐contoured gross target volumes (GTVs) and organs‐at‐risk (OARs) for eight OMD cases. RT and RO contours were compared against consensus RO Simultaneous Truth and Performance Level Estimation (RO‐STAPLE) contours using the Dice similarity coefficient (DICE), mean distance to agreement (MDA), planning target volume (PTV) D95 and OAR D0.5cc using the Wilcoxon signed‐rank test. Moreover, an RO qualitatively scored all contours using a 5‐point Likert scale. Results: We found very good geometric accuracy with average (±standard deviation) GTV DICE of 0.82 ± 0.06 for RTs and 0.85 ± 0.09 for ROs and MDA of 0.88 ± 0.03 mm for RT and 0.75 ± 0.05 mm for ROs relative to the RO‐STAPLE. Qualitative GTV Likert scores were excellent, 4.8/5 for RTs and 4.7/5 for ROs. Mean percent difference in PTV D95 compared to RO‐STAPLE was small but significantly higher for RTs (0.5% ± 1.5%) compared with ROs (−0.7% ± 1.9%, p < 0.05). Mean relative change in OAR D0.5cc results was small with −1% ± 6% for RTs and −1% ± 12% for ROs. Conclusions: Here we provide the first report of geometric and dosimetric contouring uncertainty for MR‐guided online ART for OMD. Our results show that RT re‐contouring maintains similar performance for eligible targets and OARs compared with RO contours, establishing the initial feasibility of an RT‐led workflow.